Abstract: The invention is dental floss applicator and interdental stimulator that is flexible and also includes a guard to ensure that the dental floss has not been used or otherwise tampered with. Users can adjust the angle of the dental floss applicator and stimulator into a configuration that best suits their particular needs. When flex adjusted, the applicator is able to hold its new configuration while maintaining sufficient strength to allow the user to comfortably maneuver the apparatus to properly floss the teeth or stimulate the gums. Furthermore, the invention is disposable, rendering it convenient to use after a meal when the user is away from a private bathroom setting, such as at a home or other lodging.

Abstract: The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.

Abstract: This invention provides compositions, methods and process of producing extracts from Xanthoceras sorbifolia. The extract comprises alkaloids, coumarins, saccharides, proteins, polysaccharides, glycosides, saponins, tannins, acid, flavonoids and others. The composition can be used for treating cancer, arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, dizziness, kidney disorder, impotence and premature ejaculation; for preventing cerebral aging; for improving memory, cerebral functions; or for curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease, autism, brain trauma, Parkinson's disease or other diseases caused by cerebral dysfunctions, and treating arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, dizziness, kidney disorder.

Abstract: A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a yeast beta-glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal. The above therapeutic composition may further comprise antitumor antibodies or cancer vaccine composition, wherein the antitumor activities of the antitumor antibodies or the cancer vaccine composition are enhanced by the yeast glucan.

Abstract: This invention is directed to a food container comprising a lid and a base. The lid and base form three seals, including a locking seal, to prevent the leakage or spoilage of food during transport or temporary storage. Blades on the lid sealing edge and blades on the base sealing edge strengthen said edges, and further reinforce the seals formed between the lid and base. The lid and base, separately or when assembled, are stably stackable requiring a minimal amount of storage space.

Abstract: This invention provides a recombinant super-compound interferon or an equivalent thereof with changed spatial configuration. The super-compound interferon possesses anti-viral or anti-tumor activity and, therefore, is useful in preventing and treating viral diseases and cancers. This invention also provides an artificial gene which codes for the super-compound interferon or its equivalent. Finally, this invention provides methods for producing recombinant super-compound interferon or its equivalent and various uses of said interferon.

Abstract: This invention provides a method of improving operational effectiveness in a clinical trial, the method comprises the steps of: obtaining historical clinical trial operation data for a disease condition; normalizing data from different clinical trials; grouping different clinical trials into groups; and calculating Site Effectiveness Index (SEI), wherein the SEI is useful for improving operational effectiveness in a clinical trial. In one embodiment, using the method disclosed herein would result in reducing the cost for the clinical trial.

Abstract: The present invention provides a method for analyzing characteristics of a particulate, comprising: selecting at least one particulate in a fluid; positioning said selected particulate in the vicinity of a pair of electrodes; applying a programmed voltage signal for generating a spatially inhomogeneous electric field between said pair of electrodes; detecting the movement of the particulate while applying said programmed voltage signal to create a time-series data corresponding to said movement of the particulate; and analyzing the characteristics of said particulate based on said time-series data.

Abstract: The present invention relates to an extract from bacterial strains useful as a treatment for disorders such as digestive or urinary tract disorders, compositions comprising the extract, and processes of making the extract from media that do not pose a risk of prion diseases.

Abstract: There is provided an air intake for a vacuum-conveyance waste collection system, to form a high-speed air flow by allowing air to enter a conveying line through which waste being put into a waste receiving device is conveyed to a central waste collection station.

Abstract: The present invention is related to complementarity determining region (cdr)-grafted humanized r24 antibodies that bind to the gd3 ganglioside antigen. The humanized antibodies disclosed herein have characteristics that are comparable or superior to the murine r24 antibody, and the humanized antibodies are useful in treating cancer (e.g. Melanoma).

Abstract: The present invention is directed in particular to dipeptide-like compounds derived from functionally substituted amino acids, having fatty acid chains bound thereto through amidification of the amine functional groups of said dipeptide-like compounds, one end portion of which bears an accessory functional side chain spacer, with the other end portion being an acid group either in neutral or charged state. Compounds of the present invention have immunomodulating properties like adjuvants, In addition, compounds of the invention can be grafted on a given antigen in order to modulate or tune the immune response or can be equally grafted on a pharmaceutical carrier to enhance the therapeutic effect or targeting thereof. Accordingly, compounds of the invention find use in human and veterinary medicine both as immunogens and diagnostic tools.

Abstract: This invention provides a method for identifying cells expressing a target single chain antibody (scFv) directed against a target antigen from a collection of cells that includes cells that do not express the target scFv, comprising the step of combining the collection of cells with an anti-idiotype directed to an antibody specific for the target antigen and detecting interaction, if any, of the anti-idiotype with the cells, wherein the occurrence of an interaction identifies the cell as one which expresses the target scFv. This invention also provides a method for making a single chain antibody (scFv) directed against an antigen, wherein the selection of clones is made based upon interaction of those clones with an appropriate anti-idiotype, and heretofore inaccessible scFv so made. This invention provides the above methods or any combination thereof. Finally, this invention provides various uses of these methods.

Abstract: This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.

Abstract: This invention provides a recombinant super-compound interferon or an equivalent thereof with changed spatial configuration. The super-compound interferon possesses anti-viral or anti-tumor activity and therefore is useful to prevent and treat viral diseases and cancers. This invention also provides an artificial gene which codes for the super-compound interferon or its equivalent. Finally, this invention provides methods to produce recombinant super-compound interferon or its equivalent and various uses of said interferon.

Abstract: Sulfenamide derivatives of 4-alkyl substituted 2-mercapto benzothiazole (4m-MBT) as accelerators used in vulcanizable rubber composition having improved ‘Reversion Resistance’ and ‘Modulus & Hardness Stabilization’ properties for sulphur vulcanized tire compounds predominantly based on Natural Rubber or its blends with Polybutadiene (BR) and styrene butadiene rubber (SBR) in which Natural Rubber is the major component thereby improving the overall tire performance, ride safety and tyre service life.

Abstract: This patent presents a method for measuring the concentration of biodiesel in a homogeneous biodiesel-diesel oil mixture using mid infrared radiation for use as fabrication monitor, quality control, law enforcement and multi-fueled vehicles. The method is characterized by the use of mid infrared absorption measurement in the range from 1870 to 1600 cm?1 (5347.6 to 6250.0 nm) which corresponds to the carbonyl group absorption peak (C?O) that is only present in biodiesel. Both intensity and area of the carbonyl absorption peak present power law dependence with the biodiesel percentile in the biodiesel-diesel oil mixture.